Just a moment, the page is loading...

Interventional Oncology - TheraSphere - TheraSphere dosimetry in non-HCC indications especially mCRC

Proposals may be submitted at any time and will be reviewed on a quarterly basis throughout 2021. All submissions must be in full proposal form to be reviewed by committee, to render a formal decision.



Interventional Oncology

©2022 Boston Scientific Corporation or its affiliates. All rights reserved.